cardiovascular
Smoke From the Canadian Wildfires May Worsen Cardiac Conditions
AHA: Warn patients that wildfire smoke contains microscopic particles that can aggravate both the respiratory ...
JUNE 8, 2023
Polypill Reduces Cardiovascular Risk
Daily use of a polypill composed of a statin, a beta-blocker, an angiotensin-converting enzyme inhibitor and ...
MAY 25, 2021
Remote Monitoring for Diabetes, Heart Disease
Mobile technology is a powerful tool for helping patients with medication-induced heart problems and with diabetes.
MARCH 1, 2021
Reduced Prasugrel Doses Associated With Lower Bleeding Risk in Some Heart Patients
A reduced dose of the antiplatelet prasugrel was as effective and safe as a standard dose of ticagrelor for certain ...
JULY 28, 2020
Boost in Serum EPA Levels From Prescription Fish Oil Drives Heart Benefits
CC.20/WCC: Higher levels of the omega-3 fatty acid EPA found in the blood—and not a decrease in triglyceride ...
APRIL 3, 2020
PCI and Bypass for Stable CVD: Where’s the Benefit?
The word is finally in from the massive multicenter, international ISCHEMIA trial: For patients with severe but ...
JANUARY 15, 2020
Low-Dose Colchicine Reduces CV Events After MI
Long-term treatment with low-dose colchicine significantly decreases major adverse cardiovascular events among ...
JANUARY 14, 2020
Stopping Aspirin Post-PCI: A Matter of Timing
Withdrawing aspirin therapy and continuing ticagrelor monotherapy three months after PCI in patients with ...
JANUARY 14, 2020
Farxiga Granted New Indication for CV Reduction in Diabetic HF Patients
The FDA granted a new indication for dapliglozin to reduce the risk for hospitalization for heart failure in adults ...
OCTOBER 21, 2019
ESC Releases Guidelines on Diabetes and CVD
The guidelines provide state-of-the-art information about preventing and managing the effects of diabetes on the ...
SEPTEMBER 4, 2019
